The Patent Finder

Qilu Pharmaceutical Co., Ltd.

Also on record
Records under this name other than the patents Qilu Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Showing 1 to 3 of 3 · Back to Qilu Pharmaceutical Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,938,301Dihydropyrimido fused ring derivative as HBV inhibitor
Lapsed on the fee record
Ended Apr 10, 2026 · USPTO record
Lapsed on the fee recordEnded Apr 10, 2026USPTO record
US 8,637,681Pyrrolyl substituted dihydroindol-2-one derivatives, preparation methods and uses thereof
Lapsed on the fee record
Ended Jan 28, 2018 · USPTO record
Lapsed on the fee recordEnded Jan 28, 2018USPTO record
US 6,875,890Method of producing N, N-dimethyl glycine hydrochloride
Formerly held
Lapsed on the fee record
Ended Apr 5, 2017 · USPTO record
Lapsed on the fee recordEnded Apr 5, 2017USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited